NCT00220649View on ClinicalTrials.gov

Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2004

Conditions
Pancreatic Neoplasms
Interventions
DRUG

gemcitabine; irinotecan; leucovorin; 5-fluorouracil; oxaliplatin

Trial Locations (1)

10019

St. Luke's-Roosevelt Hospital Center, New York

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

St. Luke's-Roosevelt Hospital Center

OTHER

NCT00220649 - Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas | Biotech Hunter | Biotech Hunter